Key facts
- Annaida Technologies’s last known valuation is $5.9M (Apr 2020).
- It has raised $1.3M; the latest was Later Stage VC in Apr 2025.
- Notable investors include MassChallenge, European Innovation Council, Venture Kick, European Commission, European Union — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Annaida Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Annaida Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Annaida Technologies
Developer of a healthcare device designed to perform microscopic nuclear magnetic resonance. The company's device can shrink to suit the embryo scale and delivers sensitivity to study microscopic samples, enabling medical researchers to have a non-invasive embryo viability screening for in-vitro fertilization, as well as in biochemical research.
- Sector
- Healthcare
- HQ
- Lausanne, Switzerland
- Founded
- 2018
- Employees
- 10
- Website
- annaida.ch/
- Ownership
- Privately Held (backing)
Annaida Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Annaida Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Annaida Technologies in its N-PORT filings yet. We sweep new filings monthly.